Three-gene signature predicts disease progression of non-muscle invasive bladder cancer

The clinical grades and staging methods currently employed for bladder cancer (BC) are inadequate for assessing treatment outcomes for non-muscle invasive bladder cancer (NMIBC). We have developed a clinically applicable quantitative real-time PCR (qPCR) gene signature to predict the progression of...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: JEONG, PILDU, HA, YUN-SOK, CHO, IN-CHANG, YUN, SEOK-JOONG, YOO, EUN SANG, KIM, ISAAC YI, CHOI, YUNG HYUN, MOON, SUNG-KWON, KIM, WUN-JAE
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: D.A. Spandidos 2011
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3406413/
https://ncbi.nlm.nih.gov/pubmed/22848249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2011.309
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak